Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-08

Clinical Trial Update: Pancreatic Enzyme Supplementation for Celiac Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update on using pancreatic enzyme supplementation for celiac disease; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Celiac Disease | Phase 4 | Status: TERMINATED | Results posted: 2021-02-08